Hut 8 Corp vs Kenvue Inc. Common Stock — how do they compare? Hut 8 Corp trades at $82.73 (market cap $9.82B), while Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.5× Hut 8 Corp's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Hut 8 Corp pays none. Which is the better fit depends on your goals.
| HUT | KVUE | |
|---|---|---|
Market Cap | $9.82B | $34.06B |
Volume | 10,272,678 | 23,267,228 |
Sector | Financials | Consumer Staples |
52-Week High | $133.02 | $19.83 |
52-Week Low | $33.76 | $14.11 |
Typical Hold Time | 11 Days | — |
Enterprise Value | $17.25B | $41.56B |
Dividend Yield | — | 4.74% |
Signals from Pluang's Aura AI — not financial advice
Hut 8 Corp. (HUT) trades at $81.20, down 9.07% amid a bearish technical signal. The company reported a net loss of $226.15 million in 2025 despite revenue of $235.12 million, with negative cash flow from operations. Recent news highlights a $1.07 billion credit facility and strong analyst buy ratings, with a consensus price target of $162.69 suggesting significant upside potential.
The outlook is mixed: robust analyst support and AI infrastructure growth opportunities contrast with persistent losses and high valuation ratios. Key risks include execution on profitability and sensitivity to sector sentiment. The stock's near-term direction hinges on earnings improvement and contract execution.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →